Identifying Resistant Cancers Earlier

Identifying Resistant Cancers Earlier

Supported by the MIT-Madrid M+Visión Consortium, Team Tx Response is working on a way to measure the effectiveness of cancer therapies and identify resistant cancers early in treatment.